Alpha-fetoprotein levels in children with sudden muscle weakness
Part of Brain & nervous system, Cancer, Immune system & allergy, Infections clinical trials.
This study looks at whether a blood test for alpha-fetoprotein (AFP) can help identify the cause of sudden muscle weakness (acute flaccid paralysis) in children. It may help doctors understand and diagnose this condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 1 month and 16 years old
- Your child is admitted to the pediatric emergency or intensive care unit
- Your child has or is suspected to have sudden muscle weakness (acute flaccid paralysis)
- The weakness is thought to be due to a nerve problem (neurogenic cause)
- Your child has complete medical records and a clear clinical history
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how children with Guillain-Barré Syndrome (GBS) recover over time. It can help doctors understand what treatments work best and improve care for kids with this condition where the body's immune system attacks the nerves, causing sudden muscle weakness.
This study looks at how the muscles in the body grow in infants and young children with spastic cerebral palsy (a type of movement difference). It may help doctors better understand normal growth patterns and how care choices affect muscle development.
This study looks at whether a protein in the blood, called neurofilaments, can help doctors diagnose amyotrophic lateral sclerosis (ALS) more accurately. If you have symptoms that might be ALS, a simple blood test taken during your regular care could help provide answers.
This study uses ultrasound to look at muscle shape and function in children with spastic cerebral palsy. It aims to see how these muscle features relate to movement abilities, which could help guide future treatments.
This study uses artificial intelligence to analyze muscle MRI scans in people with genetically confirmed neuromuscular diseases. It aims to improve how these conditions are diagnosed and tracked.
This study is testing whether a blood test can detect traumatic brain injury (TBI) in children. If successful, it could offer a quicker, less invasive way to diagnose concussions and other head injuries, reducing the need for CT scans or MRIs.
Hear when a new Transverse Myelitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.